Healius Future Growth
Future criteria checks 3/6
Healius's revenue is forecast to decline at 4.8% per annum while its annual earnings are expected to grow at 90.1% per year. EPS is expected to grow by 103.8% per annum. Return on equity is forecast to be 2.3% in 3 years.
Key information
90.1%
Earnings growth rate
103.8%
EPS growth rate
Healthcare earnings growth | 24.1% |
Revenue growth rate | -4.8% |
Future return on equity | 2.3% |
Analyst coverage | Good |
Last updated | 04 Dec 2024 |
Recent future growth updates
Recent updates
Is Healius Limited (ASX:HLS) Trading At A 50% Discount?
Mar 15At AU$3.07, Is It Time To Put Healius Limited (ASX:HLS) On Your Watch List?
Feb 06Here's Why Healius (ASX:HLS) Can Manage Its Debt Responsibly
Dec 02Is Now An Opportune Moment To Examine Healius Limited (ASX:HLS)?
Oct 13Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?
Aug 02Why Healius Limited (ASX:HLS) Could Be Worth Watching
May 23Healius Limited's (ASX:HLS) Prospects Need A Boost To Lift Shares
Apr 02Healius (ASX:HLS) Is Paying Out A Larger Dividend Than Last Year
Feb 25Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 1,465 | 21 | 162 | 232 | 8 |
6/30/2026 | 1,398 | 14 | 144 | 215 | 9 |
6/30/2025 | 1,677 | 195 | 223 | 282 | 7 |
6/30/2024 | 1,746 | -636 | 203 | 267 | N/A |
12/31/2023 | 1,692 | -984 | 217 | 284 | N/A |
9/30/2023 | 1,699 | -682 | 237 | 309 | N/A |
6/30/2023 | 1,707 | -380 | 257 | 333 | N/A |
12/31/2022 | 1,839 | 35 | 313 | 407 | N/A |
9/30/2022 | 2,064 | 164 | 403 | 497 | N/A |
6/30/2022 | 2,289 | 292 | 493 | 587 | N/A |
12/31/2021 | 2,292 | 226 | 549 | 624 | N/A |
9/30/2021 | 2,103 | 146 | 506 | 575 | N/A |
6/30/2021 | 1,914 | 66 | 464 | 526 | N/A |
3/31/2021 | 1,802 | 75 | 460 | 512 | N/A |
12/31/2020 | 1,690 | 83 | 456 | 497 | N/A |
9/30/2020 | 1,630 | 83 | 395 | 452 | N/A |
6/30/2020 | 1,570 | 83 | 333 | 407 | N/A |
12/31/2019 | 1,502 | 110 | 99 | 233 | N/A |
9/30/2019 | 1,534 | 83 | 49 | 180 | N/A |
6/30/2019 | 1,566 | 57 | -2 | 128 | N/A |
3/31/2019 | 1,785 | 29 | 23 | 140 | N/A |
12/31/2018 | 1,752 | 2 | 48 | 153 | N/A |
9/30/2018 | 1,728 | 3 | 74 | 177 | N/A |
6/30/2018 | 1,705 | 4 | 99 | 202 | N/A |
3/31/2018 | 1,694 | -256 | N/A | 215 | N/A |
12/31/2017 | 1,683 | -516 | N/A | 227 | N/A |
9/30/2017 | 1,671 | -516 | N/A | 220 | N/A |
6/30/2017 | 1,659 | -517 | N/A | 212 | N/A |
3/31/2017 | 1,648 | -260 | N/A | 219 | N/A |
12/31/2016 | 1,637 | -3 | N/A | 227 | N/A |
9/30/2016 | 1,639 | 18 | N/A | 256 | N/A |
6/30/2016 | 1,642 | 38 | N/A | 285 | N/A |
12/31/2015 | 1,595 | 126 | N/A | 270 | N/A |
9/30/2015 | 1,587 | 121 | N/A | 255 | N/A |
6/30/2015 | 1,580 | 117 | N/A | 239 | N/A |
3/31/2015 | 1,596 | 127 | N/A | 256 | N/A |
12/31/2014 | 1,572 | 118 | N/A | 271 | N/A |
9/30/2014 | 1,548 | 116 | N/A | 266 | N/A |
6/30/2014 | 1,524 | 115 | N/A | 261 | N/A |
3/31/2014 | 1,501 | 134 | N/A | 256 | N/A |
12/31/2013 | 1,478 | 131 | N/A | 243 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HLS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: HLS is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: HLS is expected to become profitable in the next 3 years.
Revenue vs Market: HLS's revenue is expected to decline over the next 3 years (-4.8% per year).
High Growth Revenue: HLS's revenue is forecast to decline over the next 3 years (-4.8% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HLS's Return on Equity is forecast to be low in 3 years time (2.3%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 00:23 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Healius Limited is covered by 30 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Dennis Hulme | APP Securities Pty Ltd. |
Russell Wright | Barclay Pearce Capital Pty Limited |
Benjamin Brayshaw | Barrenjoey Markets Pty Limited |